生物类似纳塔利祖马布 (PB006) 与其参考药物的药理动力学和药理动力学相似性:随机对照试验
Hendrik Wessels1, Oliver von Richter2, Maria Velinova3
1Polpharma Biologics S.A, Gdansk, Poland.
Expert opinion on biological therapy
|December 4, 2023
概括
生物类似的PB006 (Tyruko®) 显示出与参考纳塔利祖马布 (Tysabri®) 的药理动力学和药理动力学相似性. 这项研究证实了两种治疗方法之间的可比安全性和免疫性概况.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- PB006 (Tyruko®) 是一种已批准的纳塔利祖马布 (Tysabri®) 的生物类似药.
- 纳塔利祖马布是一种用于治疗某些自身免疫性疾病的生物疗法.
- 证明生物相似性对于监管批准和治疗互换性至关重要.
研究的目的:
- 为了确认PB006和参考纳塔利祖马布 (ref-NTZ) 之间的药理动力学 (PK) 和药理动力学 (PD) 相似性.
- 与ref-NTZ.Z.相比,评估PB006的安全性,耐受性和免疫性.
主要方法:
- 这是一项多中心,双盲,随机,单剂量研究,涉及453名健康参与者.
- 参与者接受了PB006或美国许可/欧盟批准的ref-NTZ (3mg/kg输液).
- 帕克基因终点包括血清度; 帕克基因终点评估了CD19+细胞计数和α4-整合素受体和.
主要成果:
- 初级PK终点得到满足,血清度比在0.8-1.25的相似度范围内.
- 主要PD终点 (CD19+细胞,α4-整合素和) 也符合相似性标准.
- 在PB006和ref-NTZ之间没有观察到安全性,耐受性或免疫性方面的显著差异.
结论:
- PB006表现出与参考纳塔利祖马布相似的PK/PD行为.
- 这项研究证实PB006是一种治疗上相当于纳塔利祖马布的生物类药物.
- 这些发现支持使用PB006作为Tysabri®的生物类似替代品.
相关概念视频
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
186
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
186
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
157
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
157
Nonlinear Pharmacokinetics: Overview
390
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
390
Nonlinear Pharmacokinetics: Causes of Nonlinearity
202
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
202
Pharmacodynamics: Overview and Principles
1.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.2K


